After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, MEDP falls under the Healthcare sector while operating within the Diagnostics & Research industry segment. The current market capitalization of Medpace Holdings Inc is $13.15B. A total of 0.52 million shares were traded on the day, compared to an average of 496.81K shares.
In the most recent transaction, EWALD STEPHEN P sold 3,000 shares of MEDP for 450.00 per share on Jul 28 ’25. After the transaction, the General Counsel & Corp. Secy. now owns 10,343 company shares. In a previous transaction on Jul 28 ’25, BURWIG SUSAN E sold 7,500 shares at 450.14 per share. MEDP shares that Exec. VP, Operations owns now total 57,500.
Among the insiders who sold shares, Troendle August J. disposed of 48,487 shares on Jul 28 ’25 at a per-share price of $451.69. This resulted in the CEO holding 962,615 shares of MEDP after the transaction. In another insider transaction, GEIGER JESSE J sold 41,801 shares at $453.11 per share on Jul 24 ’25. Company shares held by the President now total 36,503.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, MEDP has a high of $501.30 and a low of $250.05.
As of this writing, MEDP has an earnings estimate of $3.55 per share for the current quarter. EPS was calculated based on a consensus of 5.0 estimates, with a high estimate of $3.66 per share and a lower estimate of $3.38. The company reported an EPS of $3.01 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. MEDP’s latest balance sheet shows that the firm has $461.30M in Cash & Short Term Investments as of fiscal 2021. There were $130.97M in debt and $557.22M in liabilities at the time. Its Book Value Per Share was $6.15, while its Total Shareholder’s Equity was $952.93M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MEDP is Buy with a score of 3.00.
